-
1
-
-
79958811114
-
The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report
-
Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28.
-
(2011)
Kidney Int
, vol.80
, pp. 17-28
-
-
Levey, A.S.1
de Jong, P.E.2
Coresh, J.3
-
2
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
3
-
-
70350741160
-
Cardiovascular and noncardiovascular mortality among patients starting dialysis
-
de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-9.
-
(2009)
JAMA
, vol.302
, pp. 1782-1789
-
-
de Jager, D.J.1
Grootendorst, D.C.2
Jager, K.J.3
-
4
-
-
0018689153
-
Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification
-
Utermann G, Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 1979; 99: 333-43.
-
(1979)
Eur J Biochem
, vol.99
, pp. 333-343
-
-
Utermann, G.1
Beisiegel, U.2
-
5
-
-
0018855123
-
Human apolipoprotein A-IV. Intestinal origin and distribution in plasma
-
Green PH, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911-9.
-
(1980)
J Clin Invest
, vol.65
, pp. 911-919
-
-
Green, P.H.1
Glickman, R.M.2
Riley, J.W.3
Quinet, E.4
-
6
-
-
12444321950
-
Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls
-
Ezeh B, Haiman M, Alber HF et al. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 2003; 44: 1523-9.
-
(2003)
J Lipid Res
, vol.44
, pp. 1523-1529
-
-
Ezeh, B.1
Haiman, M.2
Alber, H.F.3
-
7
-
-
0025343019
-
Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells
-
Steinmetz A, Barbaras R, Ghalim N et al. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 1990; 265: 7859-63.
-
(1990)
J Biol Chem
, vol.265
, pp. 7859-7863
-
-
Steinmetz, A.1
Barbaras, R.2
Ghalim, N.3
-
8
-
-
0022465661
-
The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine
-
Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 1986; 878: 7-13.
-
(1986)
Biochim Biophys Acta
, vol.878
, pp. 7-13
-
-
Stein, O.1
Stein, Y.2
Lefevre, M.3
Roheim, P.S.4
-
9
-
-
0025248437
-
Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV
-
Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 1990; 265: 4266-72.
-
(1990)
J Biol Chem
, vol.265
, pp. 4266-4272
-
-
Goldberg, I.J.1
Scheraldi, C.A.2
Yacoub, L.K.3
Saxena, U.4
Bisgaier, C.L.5
-
10
-
-
0021928993
-
Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV
-
Steinmetz A, Utermann G. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 1985; 260: 2258-64.
-
(1985)
J Biol Chem
, vol.260
, pp. 2258-2264
-
-
Steinmetz, A.1
Utermann, G.2
-
11
-
-
0028222323
-
Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity
-
Guyard-Dangremont V, Lagrost L, Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 1994; 35: 982-92.
-
(1994)
J Lipid Res
, vol.35
, pp. 982-992
-
-
Guyard-Dangremont, V.1
Lagrost, L.2
Gambert, P.3
-
12
-
-
0029791322
-
Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
-
Duverger N, Tremp G, Caillaud JM et al. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 1996; 273: 966-8.
-
(1996)
Science
, vol.273
, pp. 966-968
-
-
Duverger, N.1
Tremp, G.2
Caillaud, J.M.3
-
13
-
-
0030944085
-
Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
-
Cohen RD, Castellani LW, Qiao JH et al. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 1997; 99: 1906-16.
-
(1997)
J Clin Invest
, vol.99
, pp. 1906-1916
-
-
Cohen, R.D.1
Castellani, L.W.2
Qiao, J.H.3
-
14
-
-
0033859318
-
Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease
-
Kronenberg F, Stuhlinger M, Trenkwalder E et al. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 2000; 36: 751-7.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 751-757
-
-
Kronenberg, F.1
Stuhlinger, M.2
Trenkwalder, E.3
-
15
-
-
0035296412
-
The relationship between plasma apolipoprotein A-IV levels and coronary heart disease
-
Manpuya MW, Guo J, Zhao Y. The relationship between plasma apolipoprotein A-IV levels and coronary heart disease. Chin Med J (Engl) 2001; 114: 275-9.
-
(2001)
Chin Med J (Engl)
, vol.114
, pp. 275-279
-
-
Manpuya, M.W.1
Guo, J.2
Zhao, Y.3
-
16
-
-
77952911623
-
Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients
-
Omori M, Watanabe M, Matsumoto K et al. Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients. Ther Apher Dial 2010; 14: 341-8.
-
(2010)
Ther Apher Dial
, vol.14
, pp. 341-348
-
-
Omori, M.1
Watanabe, M.2
Matsumoto, K.3
-
17
-
-
33748744794
-
Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria
-
Lingenhel A, Lhotta K, Neyer U et al. Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria. J Lipid Res 2006; 47: 2071-9.
-
(2006)
J Lipid Res
, vol.47
, pp. 2071-2079
-
-
Lingenhel, A.1
Lhotta, K.2
Neyer, U.3
-
18
-
-
0036154170
-
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure
-
Kronenberg F, Kuen E, Ritz E et al. Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J Am Soc Nephrol 2002; 13: 461-9.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 461-469
-
-
Kronenberg, F.1
Kuen, E.2
Ritz, E.3
-
19
-
-
84869889876
-
Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D Study
-
Kollerits B, Krane V, Drechsler C et al. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus-a post hoc analysis of the 4D Study. J Intern Med 2012; 272: 592-600.
-
(2012)
J Intern Med
, vol.272
, pp. 592-600
-
-
Kollerits, B.1
Krane, V.2
Drechsler, C.3
-
20
-
-
15444365792
-
The role of apolipoprotein AIV on the control of food intake
-
Qin X, Tso P. The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets 2005; 6: 145-51.
-
(2005)
Curr Drug Targets
, vol.6
, pp. 145-151
-
-
Qin, X.1
Tso, P.2
-
21
-
-
33645452928
-
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study
-
Boes E, Fliser D, Ritz E et al. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 2006; 17: 528-36.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 528-536
-
-
Boes, E.1
Fliser, D.2
Ritz, E.3
-
22
-
-
0029101292
-
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis
-
Kronenberg F, Konig P, Neyer U et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 110-20.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 110-120
-
-
Kronenberg, F.1
Konig, P.2
Neyer, U.3
-
23
-
-
0033866167
-
Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations
-
Sun Z, Larson IA, Ordovas JM, Barnard JR, Schaefer EJ. Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations. Atherosclerosis 2000; 151: 381-8.
-
(2000)
Atherosclerosis
, vol.151
, pp. 381-388
-
-
Sun, Z.1
Larson, I.A.2
Ordovas, J.M.3
Barnard, J.R.4
Schaefer, E.J.5
-
24
-
-
80355125183
-
Do diabetes and depressed mood affect associations between obesity and quality of life in postmenopause? Results of the KORA-F3 Augsburg population study
-
Heidelberg DA, Holle R, Lacruz ME, Ladwig KH, von Lengerke T. Do diabetes and depressed mood affect associations between obesity and quality of life in postmenopause? Results of the KORA-F3 Augsburg population study. Health Qual Life Outcomes 2011; 9: 97.
-
(2011)
Health Qual Life Outcomes
, vol.9
, pp. 97
-
-
Heidelberg, D.A.1
Holle, R.2
Lacruz, M.E.3
Ladwig, K.H.4
von Lengerke, T.5
-
25
-
-
84857735644
-
Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study
-
Rathmann W, Kowall B, Tamayo T et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 2012; 44: 170-7.
-
(2012)
Ann Med
, vol.44
, pp. 170-177
-
-
Rathmann, W.1
Kowall, B.2
Tamayo, T.3
-
26
-
-
0028174206
-
Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides
-
Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318-28.
-
(1994)
J Lipid Res
, vol.35
, pp. 1318-1328
-
-
Kronenberg, F.1
Lobentanz, E.M.2
Konig, P.3
Utermann, G.4
Dieplinger, H.5
-
27
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
-
(2009)
Ann Intern Med
, vol.150
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
-
28
-
-
84855232027
-
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models
-
Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 2012; 31: 101-13.
-
(2012)
Stat Med
, vol.31
, pp. 101-113
-
-
Pencina, M.J.1
D'Agostino Sr, R.B.2
Demler, O.V.3
-
29
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
-
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-72.
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino Sr, R.B.2
D'Agostino Jr, R.B.3
Vasan, R.S.4
-
30
-
-
0026576443
-
Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease
-
Dieplinger H, Lobentanz EM, Konig P et al. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest 1992; 22: 166-74.
-
(1992)
Eur J Clin Invest
, vol.22
, pp. 166-174
-
-
Dieplinger, H.1
Lobentanz, E.M.2
Konig, P.3
-
31
-
-
0037408130
-
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients
-
Kronenberg F, Lingenhel A, Neyer U et al. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003; 84: S113-6.
-
(2003)
Kidney Int Suppl
, vol.84
, pp. S113-S116
-
-
Kronenberg, F.1
Lingenhel, A.2
Neyer, U.3
-
32
-
-
0035134429
-
High serum apolipoprotein AIV levels in renal transplant recipients
-
Massy ZA, Kandoussi AM, Mamzer-Bruneel MF et al. High serum apolipoprotein AIV levels in renal transplant recipients. Clin Nephrol 2001; 55: 156-8.
-
(2001)
Clin Nephrol
, vol.55
, pp. 156-158
-
-
Massy, Z.A.1
Kandoussi, A.M.2
Mamzer-Bruneel, M.F.3
-
33
-
-
0023229668
-
An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysis
-
Seishima M, Muto Y. An increased apo A-IV serum concentration of patients with chronic renal failure on hemodialysis. Clin Chim Acta 1987; 167: 303-11.
-
(1987)
Clin Chim Acta
, vol.167
, pp. 303-311
-
-
Seishima, M.1
Muto, Y.2
-
34
-
-
32644469682
-
Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue
-
Haiman M, Salvenmoser W, Scheiber K et al. Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney Int 2005; 68: 1130-6.
-
(2005)
Kidney Int
, vol.68
, pp. 1130-1136
-
-
Haiman, M.1
Salvenmoser, W.2
Scheiber, K.3
-
35
-
-
0031805581
-
Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation
-
Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol 1998; 274: H1836-40.
-
(1998)
Am J Physiol
, vol.274
, pp. H1836-H1840
-
-
Qin, X.1
Swertfeger, D.K.2
Zheng, S.3
Hui, D.Y.4
Tso, P.5
-
36
-
-
73849124981
-
Emerging risk factors and markers of chronic kidney disease progression
-
Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009; 5: 677-89.
-
(2009)
Nat Rev Nephrol
, vol.5
, pp. 677-689
-
-
Kronenberg, F.1
-
37
-
-
73449112003
-
Ageing and the glomerular filtration rate: truths and consequences
-
Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009; 120: 419-28.
-
(2009)
Trans Am Clin Climatol Assoc
, vol.120
, pp. 419-428
-
-
Glassock, R.J.1
Winearls, C.2
|